BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 26, 1999
View Archived Issues
Crescendo submits two NDAs to FDA during Q3 1999
Read More
MGI Pharma makes significant progress with MGI-114 development during third quarter
Read More
Protease inhibitors for HCV infection developed at Vertex
Read More
Trademark verdict disputed by Pfizer
Read More
CDC advisory committee recommends Wyeth-Lederle's pneumococcal conjugate vaccine for routine use
Read More
Sheffield Pharmaceuticals completes inhaled steroid agreement with Elan
Read More
FP receptor agonists claimed by Procter & Gamble for bone disorders, glaucoma
Read More
New antitumor diterpenes discovered in China
Read More
Chinese researchers isolate new immunosuppressive fungal metabolite
Read More
PTPase inhibitors in early development at Novo Nordisk
Read More
Novel oncological compounds acting as antagonists of protein-carbohydrate binding
Read More
Merck's new GH secretagogues described in recent patent
Read More
Polyamine derivatives designed at U. of Florida for reduced toxicity
Read More
Patents cover Immtech's lead dicationic antifungal agents
Read More
Immtech receives patent coverage for rmCRP in platelet disorders
Read More
Agouron to commercialize Rescriptor throughout the world; anti-HIV pipeline grows
Read More
Development of OvaRex is now sole focus for AltaRex
Read More
Pharmacia & Upjohn reviews recent FDA developments for its products
Read More
Recent steps taken toward creation of Aventis
Read More
Antiepileptic potential of EPC-K1 demonstrated in rat model
Read More
LMW heparin to be marketed in U.K. and Ireland by ICN
Read More
First approval obtained for bivalirudin
Read More
